These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1979699)

  • 21. Improvement of cortical perfusion, intracellular pH, and electrocorticography by nimodipine during transient focal cerebral ischemia.
    Tally PW; Sundt TM; Anderson RE
    Neurosurgery; 1989 Jan; 24(1):80-7. PubMed ID: 2927603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nimodipine prevents early loss of hippocampal CA1 parvalbumin immunoreactivity after focal cerebral ischemia in the rat.
    Benyó Z; De Jong GI; Luiten PG
    Brain Res Bull; 1995; 36(6):569-72. PubMed ID: 7757491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage.
    Uematsu D; Araki N; Greenberg JH; Sladky J; Reivich M
    Neurology; 1991 Jan; 41(1):88-94. PubMed ID: 1985301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nimodipine on l-glutamate-induced seizures and Ca2+ influx in hippocampus in freely moving rats.
    Lu YM; Zhang JT; Zhao FQ; Li F
    Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):297-300. PubMed ID: 1807075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nimodipine on acute focal cerebral ischemia.
    Barnett GH; Bose B; Little JR; Jones SC; Friel HT
    Stroke; 1986; 17(5):884-90. PubMed ID: 3764959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
    Gemba T; Ninomiya M; Matsunaga K; Ueda M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):463-7. PubMed ID: 8474028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nimodipine on multiunit activity of several brain structures following acute global cerebral ischemia-anoxia in cats.
    Cervantes M; Chávez-Carrillo I; Antonio-Ocampo A
    Bol Estud Med Biol; 1992; 40(1-4):21-30. PubMed ID: 1296669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
    Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
    Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular accumulation of glutamate in the hippocampus induced by ischemia is not calcium dependent--in vitro and in vivo evidence.
    Ikeda M; Nakazawa T; Abe K; Kaneko T; Yamatsu K
    Neurosci Lett; 1989 Jan; 96(2):202-6. PubMed ID: 2564653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of nimodipine in cerebral ischemia or hemorrhage.
    Teasdale G; Mendelow AD; Graham DI; Harper AM; McCulloch J
    Stroke; 1990 Dec; 21(12 Suppl):IV123-5. PubMed ID: 2260136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with nimodipine and dizocilpine in a rat model of transient forebrain ischemia.
    Rod MR; Auer RN
    Stroke; 1992 May; 23(5):725-32. PubMed ID: 1579971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of nimodipine on intracellular brain pH, cortical blood flow, and EEG in experimental focal cerebral ischemia.
    Meyer FB; Anderson RE; Yaksh TL; Sundt TM
    J Neurosurg; 1986 Apr; 64(4):617-26. PubMed ID: 3950744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nimodipine inhibits calcium-independent nitric oxide synthase activity in transient focal cerebral ischemia rats and cultured mouse astroglial cells.
    Zhu D; Li R; Liu G; Hua W
    Life Sci; 1999; 65(15):PL221-31. PubMed ID: 10574230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hippocampal CA1 cell loss in a non-human primate model of transient global ischemia: a pilot study.
    Hara K; Yasuhara T; Matsukawa N; Maki M; Masuda T; Yu G; Xu L; Tambrallo L; Rodriguez NA; Stern DM; Kawase T; Yamashima T; Buccafusco JJ; Hess DC; Borlongan CV
    Brain Res Bull; 2007 Sep; 74(1-3):164-71. PubMed ID: 17683803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nimodipine decreases calcium action potentials in rabbit hippocampal CA1 neurons in an age-dependent and concentration-dependent manner.
    Moyer JR; Disterhoft JF
    Hippocampus; 1994 Feb; 4(1):11-7. PubMed ID: 8061749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Ca2+ entry blockers on kainate-induced changes in extracellular amino acids and Ca2+ in vivo.
    Lazarewicz JW; Lehmann A; Hamberger A
    J Neurosci Res; 1987; 18(2):341-4. PubMed ID: 3155423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatosensory evoked potentials quantify clinical improvement of cerebral vasospasm after intravenous administration of nimodipine.
    Lipschitz R; Davidson K; Strugo V
    S Afr Med J; 1988 Oct; 74(8):403-5. PubMed ID: 3187819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoglycaemic brain damage: effect of a dihydropyridine calcium channel antagonist in rats.
    Auer RN; Anderson LG
    Diabetologia; 1996 Feb; 39(2):129-34. PubMed ID: 8635663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.